Clover Health Investments, Corp.
CLOV
$2.67
$0.0250.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 469.83M | 456.91M | 330.68M | 322.58M | 349.90M |
| Total Other Revenue | 7.79M | 5.43M | 6.28M | 8.41M | 6.36M |
| Total Revenue | 477.62M | 462.33M | 336.96M | 330.99M | 356.26M |
| Cost of Revenue | 377.99M | 353.44M | 243.04M | 249.77M | 248.35M |
| Gross Profit | 99.63M | 108.89M | 93.92M | 81.21M | 107.91M |
| SG&A Expenses | 109.79M | 109.70M | 115.02M | 90.20M | 99.92M |
| Depreciation & Amortization | 394.00K | 466.00K | 344.00K | 339.00K | 330.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 488.18M | 463.61M | 358.41M | 340.31M | 348.60M |
| Operating Income | -10.56M | -1.27M | -21.45M | -9.32M | 7.66M |
| Income Before Tax | -10.58M | -1.27M | -21.48M | -8.79M | 7.17M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.58M | -1.27M | -21.48M | -8.79M | 7.17M |
| Earnings from Discontinued Operations | -- | -- | -611.00K | -370.00K | 238.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.58M | -1.27M | -22.09M | -9.16M | 7.41M |
| EBIT | -10.56M | -1.27M | -21.45M | -9.32M | 7.66M |
| EBITDA | -10.17M | -808.00K | -21.10M | -8.98M | 7.99M |
| EPS Basic | -0.02 | 0.00 | -0.04 | -0.02 | 0.02 |
| Normalized Basic EPS | -0.01 | 0.00 | -0.03 | -0.01 | 0.01 |
| EPS Diluted | -0.02 | 0.00 | -0.05 | -0.02 | 0.01 |
| Normalized Diluted EPS | -0.01 | 0.00 | -0.03 | -0.01 | 0.01 |
| Average Basic Shares Outstanding | 509.04M | 497.06M | 491.87M | 490.18M | 487.48M |
| Average Diluted Shares Outstanding | 509.04M | 497.06M | 491.87M | 490.18M | 495.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |